The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis
Open accessAbstract
BACKGROUND: Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insulin resistance. The objective of this study is to compare fasting glucose, fasting insulin concentrations and HOMA-IR in strength of association with incident cardiovascular disease. METHODS: We searched the PubMed, MEDLINE, EMBASE, Web of Science, ScienceDirect and Cochrane Library databases from inception to March, 2011, and screened reference lists. Cohort studies or nested case-control studies that investigated the association between fasting glucose, fasting insulin or HOMA-IR and incident cardiovascular disease, were eligible. Two investigators independently performed the article selection, data extraction and risk of bias assessment. Cardiovascular endpoints were coronary heart disease (CHD), stroke or combined cardiovascular disease. We used fixed and random-effect meta-analyses to calculate the pooled relative risk for CHD, stroke and combined cardiovascular disease, comparing high to low concentrations of glucose, insulin or HOMA-IR. Study heterogeneity was calculated with the I(2) statistic. To enable a comparison between cardiovascular disease risks for glucose, insulin and HOMA-IR, we calculated pooled relative risks per increase of one standard deviation. RESULTS: We included 65 studies (involving 516,325 participants) in this meta-analysis. In a random-effect meta-analysis the pooled relative risk of CHD (95% CI; I(2)) comparing high to low concentrations was 1.52 (1.31, 1.76; 62.4%) for glucose, 1.12 (0.92, 1.37; 41.0%) for insulin and 1.64 (1.35, 2.00; 0%) for HOMA-IR. The pooled relative risk of CHD per one standard deviation increase was 1.21 (1.13, 1.30; 64.9%) for glucose, 1.04 (0.96, 1.12; 43.0%) for insulin and 1.46 (1.26, 1.69; 0.0%) for HOMA-IR. CONCLUSIONS: The relative risk of cardiovascular disease was higher for an increase of one standard deviation in HOMA-IR compared to an increase of one standard deviation in fasting glucose or fasting insulin concentration. It may be useful to add HOMA-IR to a cardiovascular risk prediction model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both prediabetes and metabolic syndrome confer increased risk of T2D and CVD.802–804”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [803]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, a meta-analysis of the association between Homeostasis Model Assessment Insulin Resistance (HOMA-IR) and cardiovascular events used dose-response modelling to estimate that the cardiovascular risk increased by 46% per one standard deviation increase in HOMA-IR [24].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In observational studies, a reduction in HOMA-IR was also associated with a reduction in CRP 81 and cardiovascular risk. 82”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Huxley, R., Barzi, F., & Woodward, M. (2006) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,534
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Research works printed but not linked: 1
- Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Lippincott Williams & Wilkins. 112 p.
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“As described in the previous sections, T2DM is a multisystem disease with a strong correlation with CVD development [177].”
BackgroundAssociation between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
“A 2012 meta-analysis of 65 studies, which included 516,325 participants, revealed that insulin resistance, evaluated by HOMA index, was a good predictor for CVD [6].”
MethodInsulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Dekkers, O. M., Vandenbroucke, J. P., Cevallos, M., Renehan, A. G., Altman, D. G., & Egger, M. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002742 · Cited by 525
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Lim, J., Kim, J., Koo, S. H., & Kwon, G. C. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212963 · Cited by 464
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
Hong, S., Han, K., & Park, C.-Y. (2020) · BMC Medicine · doi:10.1186/s12916-020-01824-2 · Cited by 376
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease
DiNicolantonio, J. J., Lucan, S. C., & O’Keefe, J. H. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.11.006 · Cited by 354
Insulin: The master regulator of glucose metabolism
Norton, L., Shannon, C., Gastaldelli, A., & DeFronzo, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155142 · Cited by 330
Insulin resistance is a cardiovascular risk factor in humans
Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.023 · Cited by 313
Obesity and cardiovascular disease: An ESC clinical consensus statement
Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae508 · Cited by 313
Luo, E., Wang, D., Yan, G., Qiao, Y., Liu, B., Hou, J., & Tang, C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0957-3 · Cited by 304
Yun, J.-S., & Ko, S.-H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154838 · Cited by 292
Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F., & Hadaegh, F. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01121-5 · Cited by 261
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243
“(17) conducted a meta-analysis of 65 studies and found that insulin resistance determined by the homeostasis model assessment of insulin resistance was significantly associated with relative risk for CVD events.”
BackgroundLi, W., Shen, C., Kong, W., Zhou, X., Fan, H., Zhang, Y., Liu, Z., & Zheng, L. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02352-6 · Cited by 234
“Extensive research has identified IR as an independent risk factor for CVD [33–35].”
BackgroundPioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes
DeFronzo, R. A., Inzucchi, S., Abdul-Ghani, M., & Nissen, S. E. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118825376 · Cited by 223
Li, S., Guo, B., Chen, H., Shi, Z., Li, Y., Tian, Q., & Shi, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43776-5 · Cited by 215
Zhang, Z., Zhao, L., Lu, Y., Xiao, Y., & Zhou, X. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02256-5 · Cited by 194
Bray, J. J. H., Foster‐Davies, H., Salem, A., Hoole, A. L., Obaid, D. R., Halcox, J. P. J., & Stephens, J. W. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14399 · Cited by 194
“They comprised 6749 patients (inflammation evaluated in 6560, oxidative stress in 701 patients), included a median (IQR) study population of 60 (33-122) participants, and had a median (IQR) follow-up of 6 months (84-182 days).”
BackgroundLi, H., Zuo, Y., Qian, F., Chen, S., Tian, X., Wang, P., Li, X., Guo, X., Wu, S., & Wang, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01541-5 · Cited by 164
“A metaanalysis of cohort studies or nested case–control studies have shown a positive prospective relationship between insulin resistance and risk of CVD in non-diabetic adults [4].”
BackgroundInsulin Resistance, Diabetes, and Cardiovascular Risk
Paneni, F., Costantino, S., & Cosentino, F. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0419-z · Cited by 176
DiNicolantonio, J. J., O’Keefe, J. H., & Lucan, S. C. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.019 · Cited by 179
Ghasemi, A., Tohidi, M., Derakhshan, A., Hasheminia, M., Azizi, F., & Hadaegh, F. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0730-3 · Cited by 162
Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study
Georgakis, M. K., Harshfield, E. L., Malik, R., Franceschini, N., Langenberg, C., Wareham, N. J., Markus, H. S., & Dichgans, M. (2021) · Neurology · doi:10.1212/wnl.0000000000011555 · Cited by 164
“Observational data suggest that markers of insulin resistance, β-cell dysfunction, and hyperglycemia influence the risk of cardiovascular disease independently of each other.(10,11) However, data on stroke and its etiologic subtypes are lacking.”
Lu, Y., Chang, C. C., Chou, R., Tsai, Y., Liu, L.-K., Chen, L., Huang, P., & Lin, S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01391-7 · Cited by 144
Tohidi, M., Ghasemi, A., Hadaegh, F., Derakhshan, A., Chary, A., & Azizi, F. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.02.007 · Cited by 138
Zhao, Q., Zhang, T., Cheng, Y., Ma, Y., Xu, Y.-K., Yang, J., & Zhou, Y.-J. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.59840 · Cited by 139
Wang, T., Li, M., Zeng, T., Hu, R., Xu, Y., Xu, M., Zhao, Z., Chen, Y., Wang, S., Lin, H., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0202 · Cited by 137
Double diabetes: a distinct high-risk group?
Kietsiriroje, N., Pearson, S., Campbell, M., Ariëns, R. A. S., & Ajjan, R. A. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13848 · Cited by 123
“A meta-analysis of 65 studies, which included 516 325 adults without diabetes, has shown that insulin resistance, measured by homeostatic model assessment, is a good predictor of cardiovascular disease.(33) In line with these findings, insulin resistance in T1D has been associated with increased risk of cardiovascular…”
MethodObesity and cardiovascular disease: an ESC clinical consensus statement
Koskinas, K. C., Craenenbroeck, E. M. V., Antoniades, C. A., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae279 · Cited by 146
ter Horst, K. W., Schene, M. R., Holman, R., Romijn, J. A., & Serlie, M. J. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137786 · Cited by 132
Insulin signaling and its application
Thi Kim Chung, L. E., Dao, X. D., Nguyen, D. V., Luu, D. H., Bui, T. M. H., Le, T. H., Nguyen, H. T., Le, N. T., Hosaka, T., & Nguyen, T. T. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226655 · Cited by 138
Resistance training in stroke rehabilitation: systematic review and meta-analysis
Veldema, J., & Jansen, P. (2020) · Clinical Rehabilitation · doi:10.1177/0269215520932964 · Cited by 120
Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes: Mendelian randomization study
Larsson, S. C., Scott, R. A., Traylor, M., Langenberg, C., Hindy, G., Melander, O., Orho‐Melander, M., Seshadri, S. S., Wareham, N. J., & Markus, H. S. (2017) · Neurology · doi:10.1212/wnl.0000000000004173 · Cited by 126
“Insulin resistance was associated with a 76% increased risk of stroke (based on 4 studies), and high vs low fasting insulin was associated with a nonsignificant 90% higher risk (based on 2 studies).(6) The value of intensive glucose-lowering therapy for cardiovascular disease prevention in patients with T2D was questi…”
BackgroundNon-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
Caturano, A., Acierno, C., Nevola, R., Pafundi, P. C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L. E., & Sasso, F. C. (2021) · Processes · doi:10.3390/pr9010135 · Cited by 119
Handelsman, Y., Butler, J., Bakris, G. L., DeFronzo, R. A., Fonarow, G. C., Green, J. B., Grunberger, G., Januzzi, J. L., Klein, S., Kushner, P. R., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108389 · Cited by 118
Quispe, R., Martin, S. S., & Jones, S. R. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000241 · Cited by 102
“All rights rese insulin resistance index (HOMA-IR), a summary measure of insulin resistance, predicted CHD better than glucose and insulin levels alone [19].”
BackgroundPerreault, L., Davies, M., Frias, J. P., Laursen, P. N., Lingvay, I., Machineni, S., Varbo, A., Wilding, J. P. H., Wallenstein, S. O. R., & le Roux, C. W. (2022) · Diabetes Care · doi:10.2337/dc21-1785 · Cited by 87
“Insulin resistance is associated with a higher risk of cardiovascular disease (27).”
BackgroundZhang, S., Mwiberi, S., Pickford, R., Breitner, S., Huth, C., Köenig, W., Rathmann, W., Herder, C., Roden, M., Cyrys, J., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(20)30275-8 · Cited by 92
González‐González, J. G., Violante-Cumpa, J. R., Zambrano-Lucio, M., Burciaga-Jimenez, E., Morales, P., García-Campa, M., Solís, R. C., González-Colmenero, A. D., & Rodríguez‐Gutiérrez, R. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00542-5 · Cited by 98
“Interestingly, there was not a clear risk when comparing high vs low values of HOMA-IR and the development of a fatal-MACE (HR 1.31; 95% CI 0.96–1.77; I2 50”
BackgroundInfluentialHu, C., Zhang, J., Liu, J., Liu, Y., Gao, A., Zhu, Y., & Zhao, Y. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01091-8 · Cited by 95
Zhao, Q., Cheng, Y., Xu, Y.-K., Zhao, Z.-W., Liu, C., Sun, T., & Zhou, Y. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01383-7 · Cited by 91
Tsai, S., Yang, C., Liu, W.-J., & Lee, C.-L. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101934 · Cited by 98
Xun, P., Wu, Y., He, Q., & He, K. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.065565 · Cited by 90
“On the basis of available data from 4 studies, the pooled RR from a comparison of extreme quantiles of insulin concentrations for CHD was 1.50 (95% CI: 1.28, 1.77) with no significant heterogeneity among studies (I2 = 0.0%, P = 0.71).”
BackgroundInfluentialFructose-Rich Beverage Intake and Central Adiposity, Uric Acid, and Pediatric Insulin Resistance
Lin, W., Chan, T., Huang, H., Lee, C., Tsai, S., Wu, P., Wang, T., Wang, T., & Lee, C. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.12.061 · Cited by 83
Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes
Oost, L. J., Tack, C. J., & de Baaij, J. H. F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac028 · Cited by 99
Yang, W., Cai, X., Hu, J., Wen, W., Heizhati, M., Yao, X., Yao, L., Zhu, Q., Hong, J., Luo, Q., et al. (2023) · Clinical Epidemiology · doi:10.2147/clep.s395938 · Cited by 87
Insulin resistance in hidradenitis suppurativa: a case–control study
Vilanova, I., Hernández, J. L., Mata, C., Durán, C., García‐Unzueta, M. T., Portilla, V., Fuentevilla, P., Corrales, A., Gonzaléz‐Vela, M. C., González-Gay, M. Á., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14894 · Cited by 76
Semmler, G., Balcar, L., Wernly, S., Völkerer, A., Semmler, L., Hauptmann, L., Wernly, B., Aigner, E. S., Niederseer, D., & Datz, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244405 · Cited by 83
Vasomotor symptoms of menopause, autonomic dysfunction, and cardiovascular disease
Lee, E. J., Anselmo, M. F., Tahsin, C. T., Noven, M. V., Stokes, W., Carter, J. R., & Keller‐Ross, M. L. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00477.2022 · Cited by 103
Role of oxidative stress in endothelial insulin resistance
Paneni, F., Costantino, S., & Cosentino, F. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.326 · Cited by 83
Effects of intermittent fasting on cognitive health and Alzheimer’s disease
Elias, A., Padinjakara, N., & Lautenschlager, N. T. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad021 · Cited by 91
“Insulin resistance promotes atherosclerosis and subsequent vascular diseases.(27,28) In addition to the effect”
BackgroundManaging insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani, M. A., Maffei, P., & DeFronzo, R. A. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00127-x · Cited by 89
Cho, Y. K., Lee, J., Kim, H. S., Kim, H. S., Lee, M. J., Yang, D. H., Yang, D. H., Jung, C. H., Park, J., Kim, H.-K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010092 · Cited by 80
“As atherosclerosis is a dynamic process, CAC progression could be a better surrogate marker of the activity of atherosclerosis and a predictor for potential CVD events in comparison to baseline CAC [18].”
BackgroundInfluentialKosmas, C. E., Silverio, D., Tsomidou, C., Salcedo, M. D., Montan, P. D., & Guzman, E. (2018) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551418792257 · Cited by 74
Insulin resistance in obesity can be reliably identified from fasting plasma insulin
ter Horst, K. W., Gilijamse, P. W., Koopman, K. E., de Weijer, B. A., Brands, M., Kootte, R. S., Romijn, J. A., Ackermans, M. T., Nieuwdorp, M., Soeters, M. R., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.125 · Cited by 69
Bello‐Chavolla, O. Y., Antonio‐Villa, N. E., Vargas‐Vázquez, A., Martagón, A. J., Mehta, R., Arellano‐Campos, O., Gómez‐Velasco, D., Almeda‐Valdés, P., Cruz‐Bautista, I., Melgarejo-Hernández, M. A., et al. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13614 · Cited by 62
Hong, J., Zhang, R., Tang, H., Wu, S., Chen, Y., & Tan, X. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02662-3 · Cited by 73
“IR is defined as the inability of insulin to optimally stimulate the transport of glucose into the body’s cell, including hyperinsulinemia or impaired glucose tolerance [38], which plays an important role in cardiovascular diseases incidence [39].”
Zhang, X., Li, J., Zheng, S., Luo, Q., Zhou, C., & Wang, C. (2017) · Bioscience Reports · doi:10.1042/bsr20170947 · Cited by 64
Epigenetic processing in cardiometabolic disease
Costantino, S., Mohammed, S. A., Ambrosini, S., & Paneni, F. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.029 · Cited by 70
Szadkowska, A., Madej, A., Ziółkowska, K., Szymańska, M., Jeziorny, K., Mianowska, B., & Pietrzak, I. (2015) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1141381 · Cited by 62
“Insulin resistance is an important risk factor for cardiovascular disease and increased morbidity and mortality in the general population [4].”
BackgroundDecoding the Liver-Heart Axis in Cardiometabolic Diseases
Capone, F., Vacca, A., Bidault, G., Sarver, D. C., Kamińska, D., Strocchi, S., Vidal‐Puig, A., Greco, C. M., Lusis, A. J., & Schiattarella, G. G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325492 · Cited by 80
Starzak, M., Stanek, A., Jakubiak, G. K., Cholewka, A., & Cieślar, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610368 · Cited by 67
“When assessing the IR index there is a need for insulin level measurement, which is a limitation of such indexes due to their high cost and variability depending on the utilized technique [83].”
MethodN6-Adenosine Methylation (m6A) RNA Modification: an Emerging Role in Cardiovascular Diseases
Chen, Y., Ouyang, X.-P., Yu, X.-H., Novák, P., Zhou, L., He, P., & Yin, K. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10108-w · Cited by 61
“A metaanalysis revealed that IR, evaluated by Homeostasis Model Assessment (HOMA), was a better predictor of CVD events than fasting levels of insulin or glucose in adults without diabetes mellitus [127].”
MethodYamazoe, M., Hisamatsu, T., Miura, K., Kadowaki, S., Zaid, M., Kadota, A., Torii, S., Miyazawa, I., Fujiyoshi, A., Arima, H., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307612 · Cited by 65
“One previous meta-analysis described that the relative risk of CHD per 1-SD increase in HOMA-IR was higher than that in fasting insulin concentration.(21) However, this report compared insulin and HOMA-IR derived from different cohort studies and nested case–control studies, and therefore, we Table 1.”
ResultWu, Z., Cui, H., Li, W., Zhang, Y., Liu, L., Liu, Z., Zhang, W., Zheng, T., & Yang, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.918359 · Cited by 63
“Interestingly, these indexes have strong predictive abilities for the incidence and prognosis of CVD (12, 13, 15, 16, 27–29).”
MethodInfluentialIs Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
Laakso, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0684-4 · Cited by 73
Nokoff, N., Scarbro, S. L., Moreau, K. L., Zeitler, P. S., Nadeau, K. J., Juarez‐Colunga, E., & Kelsey, M. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz029 · Cited by 60
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets
Volek, J. S., Phinney, S. D., Krauss, R. M., Johnson, R. J., Saslow, L. R., Gower, B., Yancy, W. S., King, J. C., Hecht, F. M., Teicholz, N., et al. (2021) · Nutrients · doi:10.3390/nu13103299 · Cited by 57
“A substantial body of published work over the past 20 years has documented that lowcarbohydrate diets induce favorable changes in cholesterol and other CVD risk markers, especially the cluster of abnormal risk factors associated with the IR phenotype, including high triglycerides, low HDL-cholesterol, increased small,…”
BackgroundInfluentialCarbohydrate status in patients with phenylketonuria
Couce, M. L., Sánchez‐Pintos, P., Vitoria, I., de Castro, M.-J., Aldamiz-Echevarria, L. J., Medina, P. C., Marmiesse, A. F., Roca, I., Ameijeiras, Á. H., Olmos, M. Á. M., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0847-x · Cited by 66
DPP4 Activity, Hyperinsulinemia, and Atherosclerosis
Love, K. M., & Liu, Z. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab078 · Cited by 63
Park, K., Li, Q., Evcimen, N. D., Rask‐Madsen, C., Maeda, Y., Maddaloni, E., Yokomizo, H., Shinjo, T., St-Louis, R., Fu, J., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310291 · Cited by 61
“The associations of systemic insulin resistance and endogenous hyperinsulinemia with elevated risk of CVDs have been consistently shown even in the absence of diabetes mellitus and hyperglycemia.(4,5) Clinical evidence to support exogenous induced hyperinsulinemia’s role to increase CVD risk is still uncertain.”
Shared Mechanisms between Cardiovascular Disease and NAFLD
Huang, D. Q., Downes, M., Evans, R. M., Witztum, J. L., Glass, C. K., & Loomba, R. S. (2022) · Seminars in Liver Disease · doi:10.1055/a-1930-6658 · Cited by 47
Wu, Z., Cui, H., Zhang, Y., Liu, L., Zhang, W., Xiong, W., Lu, F., Peng, J., & Yang, J. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01925-0 · Cited by 51
“Previous studies have shown that IR was an independent risk factor for CVD [20, 21].”
Mirjalili, S. R., Soltani, S., Meybodi, Z. H., Marques-Vidal, P. M., Kraemer, A., & Sarebanhassanabadi, M. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01939-9 · Cited by 51
Trimarco, V., Izzo, R., Stabile, E., Rozza, F., Santoro, M., Manzi, M. V., Serino, F., Schiattarella, G. G., Esposito, G., & Trimarco, B. (2015) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-015-0087-2 · Cited by 49
“Furthermore, it has been reported that fasting glucose, fasting insulin and insulin sensitivity, as expressed by Homeostasis Model Assessment Insulin Resistance (HOMA) index, were associated with incident cardiovascular disease in individuals without diabetes [5].”
Lana, A., Rodríguez‐Artalejo, F., & López‐García, E. (2014) · Journal of Nutrition · doi:10.3945/jn.114.195230 · Cited by 61
“There is evidence that insulin resistance increases the risk of diabetes (40) and cardiovascular disease (41).”
BackgroundMetabolic Dysfunction in Hutchinson–Gilford Progeria Syndrome
Kreienkamp, R., & Gonzalo, S. (2020) · Cells · doi:10.3390/cells9020395 · Cited by 45
“It is well-established that, even without diabetes, insulin resistance is a marker of cardiovascular risk [37,38].”
BackgroundTriglyceride-Glucose Index in Non-Diabetic, Non-Obese Patients with Obstructive Sleep Apnoea
Bikov, A., Frent, S., Mészáros, M., Kunos, L., Mathioudakis, A. G., Negru, A. G., Gaiţă, L., & Mihaicuta, S. D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091932 · Cited by 47
“Hence, it is not surprising that insulin resistance is strongly associated with atherosclerosis [6] and more particularly, coronary artery disease [7].”
BackgroundInsulin resistance probability score and incident cardiovascular disease
Louie, J. Z., Shiffman, D., McPhaul, M. J., & Melander, O. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13687 · Cited by 51
Marra, A., Bondesan, A., Caroli, D., & Sartório, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051353 · Cited by 55
“Therefore, the correlations between the CBC-derived inflammation indexes and the cardiovascular risk biomarkers were assessed (i.e., HOMA-IR [56–58], TG/HDL-C [59,60], and non-HDL-C [61]).”
MethodDragonieri, S., Portacci, A., Quaranta, V. N., Carratù, P., Lázár, Z., Carpagnano, G. E., & Bikov, A. (2024) · Diseases · doi:10.3390/diseases12090224 · Cited by 51
“In turn, insulin resistance contributes to dyslipidemia [48], hyperglycemia [49], and cardiovascular consequences [50,51] in OSA.”
BackgroundWelsh, P. I., Preiss, D., Lloyd, S. M., de Craen, A. J. M., Jukema, J. W., Westendorp, R. G. J., Buckley, B. M., Kearney, P. M., Briggs, A. H., Stott, D. J., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3383-9 · Cited by 46
Kim, K., Vance, T. M., Chen, M., & Chun, O. K. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1519-7 · Cited by 44
Bellavite, P., Fazio, S., & Affuso, F. (2023) · Molecules · doi:10.3390/molecules28114491 · Cited by 46
“There is extensive scientific literature supporting the fact that IR/Hyperin should also be considered as an independent risk factor for the development of cardiovascular diseases [3,214,215].”
BackgroundMarco, M. D., Scilletta, S., Miano, N., Capuccio, S., Musmeci, M., Mauro, S. D., Filippello, A., Scamporrino, A., Bosco, G., Barbagallo, F. D. G., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112189 · Cited by 42
PREDIMED Study Investigators, Downer, M. K., Martínez‐González, M. Á., Gea, A., Stampfer, M. J., Wärnberǵ, J., Ruiz‐Canela, M., Salas‐Salvadó, J., Corella, D., Ros, E., et al. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0435-8 · Cited by 44
“This difference was expected, as both history of type 2 diabetes and poor adherence to the Mediterranean diet are risk factors for cardiovascular disease [43, 44].”
BackgroundWu, S., Shi, Y., Wang, C., Jia, Q., Zhang, N., Zhao, X., Liu, G., Wang, Y., Liu, L., Wang, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080690 · Cited by 47
“FPG, fasting plasma glucose; HDL,high density lipid protein; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; Cr, creatinine; CHO, cholesterol; BMI, body mass index; HOMA2-IR, the correctly solved computer model for homeostasis model asse…”
MethodInfluentialThe mechanism by which moderate alcohol consumption influences coronary heart disease
Mathews, M. J., Liebenberg, L., & Mathews, E. H. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0011-6 · Cited by 48
“69) (N = 17, n = 51 161) [171]”
Oral health and coronary heart disease
Mathews, M. J., Mathews, E. H., & Mathews, G. E. (2016) · BMC Oral Health · doi:10.1186/s12903-016-0316-7 · Cited by 48
Rafiee, H., Mohammadifard, N., Nouri, F., Tabatabaei, G. A., Najafian, J., Sadeghi, M., Boshtam, M., Roohafza, H., Haghighatdoost, F., Hassannejad, R., et al. (2024) · European journal of medical research · doi:10.1186/s40001-024-01728-4 · Cited by 42
“IR has been reported to be associated with both CVD risk factors and incident CVD [42, 43].”
BackgroundPhysical activity and fitness in childhood cancer survivors: A scoping review
Wogksch, M. D., Goodenough, C. G., Finch, E. R., Partin, R. E., & Ness, K. K. (2021) · Aging and Cancer · doi:10.1002/aac2.12042 · Cited by 40
Liu, C., Liu, X., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Zhao, Q., & Zhou, Y. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00915-9 · Cited by 48
“Using the homeostasis model assessment of insulin resistance (HOMA-IR), a metaanalysis of 65 trials with 516,325 individuals revealed that the possibility of coronary heart disease increased by 46% in the non-diabetic for every 1 standard deviation increase in IR [10].”
MethodWestergren, H. U., Svedlund, S., Momo, R. A., Blomster, J., Wåhlander, K., Rehnström, E., Greasley, P. J., Fritsche‐Danielson, R., Oscarsson, J., & Gan, L. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0353-1 · Cited by 40
Farhan, S., Redfors, B., Maehara, A., McAndrew, T., Ben‐Yehuda, O., Bruyne, B. D., Mehran, R., Vogel, B., Giustino, G., Serruys, P. W. J. C., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01207-0 · Cited by 43
“The DIRassociated risk of MACE observed in PROSPECT is also consistent with the literature, as a recent meta-analysis showed that HOMA-IR ≥ 5 was an independent correlate of cardiovascular events in patients without DM [37].”
ResultLi, M., Cui, M., Li, G., Liu, Y., Xu, Y., Eftekhar, S. P., & Ala, M. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2266-1503 · Cited by 37
“…516 325 non-diabetic individuals uncovered that 1 unit increase in glucose and homeostatic model assessment for insulin resistance (HOMA-IR) significantly [relative risk (RR) 1.21, 95 % CI 1.13–1.30] and (RR 1.46, 95 % CI 1.26–1.69), respectively) increases the risk of coronary heart disease [38].”
InfluentialNurkolis, F., Harbuwono, D. S., Taslim, N. A., Soegondo, S., Suastika, K., Sparringa, R. A., Mustika, A., Syam, A. F., Santini, A., Holly, J. M. P., et al. (2025) · Discover Food · doi:10.1007/s44187-025-00422-6 · Cited by 49
“…disease including polycystic ovarian syndrome, non-alcoholic liver disease (NAFLD), which is now known as metabolic dysfunction–associated steatotic liver disease (MASLD) [212], and even cardiovascular disease [61, 203], all of which are accompanied by increased concentrations of plasma insulin.”
Metadata
- Authors
- Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Gast, Karin B.
- Tjeerdema, Nathanja
- Stijnen, Theo
- Smit, Johannes W. A.
- Dekkers, Olaf M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-28
- Volume
- 7
- Issue
- 12
- Pages
- e52036
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3532497
- OpenAlex
- W2039758398
- Cited by
- 403
- References
- 33
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 60 · 2023: 50 · 2022: 52 · 2021: 40 · 2020: 35 · 2019: 26 · 2018: 17 · 2017: 15 · 2016: 14 · 2015: 19 · 2014: 18 · 2013: 4
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Universiteit Leiden
- Leids Universitair Medisch Centrum
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, HOMA-IR, fasting blood glucose, fasting insulin, incident cardiovascular disease, coronary artery disease, stroke, cardiovascular risk prediction, non-diabetic adults, risk stratification model, risk reclassification, risk prediction thresholds
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.